{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:37:11Z","timestamp":1787319431011,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,8]]},"DOI":"10.7759\/cureus.94099","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:45:11Z","timestamp":1759916711000},"source":"Crossref","is-referenced-by-count":3,"title":["Impact of Comorbidity Burden on Clinical Outcomes in Older Adults With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Ryuichi","family":"Ohta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00360-X","article-title":"Colorectal cancer","volume":"404","author":"Eng C","year":"2024","unstructured":"Eng C, Yoshino T, Ru\u00edz-Garc\u00eda E, et al.. Colorectal cancer. Lancet. 2024, 404:294-310. 10.1016\/S0140-6736(24)00360-X","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071732","article-title":"Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies","volume":"14","author":"Hossain MS","year":"2022","unstructured":"Hossain MS, Karuniawati H, Jairoun AA, et al.. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers (Basel). 2022, 14:10.3390\/cancers14071732","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2022.102246","article-title":"Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosis","volume":"80","author":"Gheybi K","year":"2022","unstructured":"Gheybi K, Buckley E, Vitry A, Roder D. Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosis. Cancer Epidemiol. 2022, 80:102246. 10.1016\/j.canep.2022.102246","journal-title":"Cancer Epidemiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00376-4","article-title":"Multimorbidity","volume":"8","author":"Skou ST","year":"2022","unstructured":"Skou ST, Mair FS, Fortin M, et al.. Multimorbidity. Nat Rev Dis Primers. 2022, 8:48. 10.1038\/s41572-022-00376-4","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7150\/jca.103438","article-title":"Impact of multimorbidity burden on mortality risk among colon cancer survivors","volume":"16","author":"Wang SH","year":"2025","unstructured":"Wang SH, Koseki M, Sheu MJ, Li HL, Lin YJ, Yang CC, Ho CH. Impact of multimorbidity burden on mortality risk among colon cancer survivors. J Cancer. 2025, 16:558-66. 10.7150\/jca.103438","journal-title":"J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2024.2598","article-title":"Primary care use and 90-day mortality among older adults undergoing cancer surgery","volume":"159","author":"Kazaure HS","year":"2024","unstructured":"Kazaure HS, Neely NB, Howard LE, Hyslop T, Shahsahebi M, Zullig LL, Oeffinger KC. Primary care use and 90-day mortality among older adults undergoing cancer surgery. JAMA Surg. 2024, 159:1170-6. 10.1001\/jamasurg.2024.2598","journal-title":"JAMA Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.01.021","article-title":"Multimorbidity and short-term overall mortality among colorectal cancer patients in Spain: a population-based cohort study","volume":"129","author":"Luque-Fernandez MA","year":"2020","unstructured":"Luque-Fernandez MA, Gon\u00e7alves K, Salamanca-Fern\u00e1ndez E, et al.. Multimorbidity and short-term overall mortality among colorectal cancer patients in Spain: a population-based cohort study. Eur J Cancer. 2020, 129:4-14. 10.1016\/j.ejca.2020.01.021","journal-title":"Eur J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2020.04.019","article-title":"Uptake of preventive services among patients with and without multimorbidity","volume":"59","author":"Ukhanova MA","year":"2020","unstructured":"Ukhanova MA, Tillotson CJ, Marino M, et al.. Uptake of preventive services among patients with and without multimorbidity. Am J Prev Med. 2020, 59:621-9. 10.1016\/j.amepre.2020.04.019","journal-title":"Am J Prev Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang A","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010, 25:603-5. 10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris CR","year":"2020","unstructured":"Harris CR, Millman KJ, van der Walt SJ, et al.. Array programming with NumPy. Nature. 2020, 585:357-62. 10.1038\/s41586-020-2649-2","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604093","article-title":"Predictors of survival after hepatic resection among patients with colorectal liver metastasis","volume":"97","author":"Wang X","year":"2007","unstructured":"Wang X, Hershman DL, Abrams JA, Feingold D, Grann VR, Jacobson JS, Neugut AI. Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer. 2007, 97:1606-12. 10.1038\/sj.bjc.6604093","journal-title":"Br J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23102","article-title":"Assessment of prognostic factors after primary tumor resection in metastatic colon cancer patients: a Veteran's Affairs Central Cancer Registry (VACCR) analysis, 1995-2008","volume":"106","author":"Gonsalves WI","year":"2012","unstructured":"Gonsalves WI, Wolpert J, Tashi T, Ganti AK, Subbiah S, Ternent C, Silberstein PT. Assessment of prognostic factors after primary tumor resection in metastatic colon cancer patients: a Veteran's Affairs Central Cancer Registry (VACCR) analysis, 1995-2008. J Surg Oncol. 2012, 106:486-90. 10.1002\/jso.23102","journal-title":"J Surg Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12643","article-title":"Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice","volume":"45","author":"Field K","year":"2015","unstructured":"Field K, Shapiro J, Wong HL, et al.. Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice. Intern Med J. 2015, 45:267-74. 10.1111\/imj.12643","journal-title":"Intern Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.01.005","article-title":"Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer","volume":"50","author":"Jehn CF","year":"2014","unstructured":"Jehn CF, B\u00f6ning L, Kr\u00f6ning H, Pezzutto A, L\u00fcftner D. Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer. Eur J Cancer. 2014, 50:1269-75. 10.1016\/j.ejca.2014.01.005","journal-title":"Eur J Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2015.06.001","article-title":"Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia","volume":"6","author":"Parakh S","year":"2015","unstructured":"Parakh S, Wong HL, Rai R, et al.. Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia. J Geriatr Oncol. 2015, 6:387-94. 10.1016\/j.jgo.2015.06.001","journal-title":"J Geriatr Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2017.11.001","article-title":"Primary tumor location and survival in the general population with metastatic colorectal cancer","volume":"17","author":"Ahmed S","year":"2018","unstructured":"Ahmed S, Pahwa P, Le D, Chalchal H, Chandra-Kanthan S, Iqbal N, Fields A. Primary tumor location and survival in the general population with metastatic colorectal cancer. Clin Colorectal Cancer. 2018, 17:e201-6. 10.1016\/j.clcc.2017.11.001","journal-title":"Clin Colorectal Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4784-9","article-title":"Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival","volume":"18","author":"Seidensticker R","year":"2018","unstructured":"Seidensticker R, Damm R, Enge J, et al.. Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival. BMC Cancer. 2018, 18:882. 10.1186\/s12885-018-4784-9","journal-title":"BMC Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2020.5701\/2018","article-title":"Colonic stent vs surgical resection of the primary tumor. Effect on survival from stage-IV obstructive colorectal cancer","volume":"112","author":"Seoane Urgorri A","year":"2020","unstructured":"Seoane Urgorri A, Saperas E, O'Callaghan Castella E, et al.. Colonic stent vs surgical resection of the primary tumor. Effect on survival from stage-IV obstructive colorectal cancer. Rev Esp Enferm Dig. 2020, 112:694-700. 10.17235\/reed.2020.5701\/2018","journal-title":"Rev Esp Enferm Dig"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.12.002","article-title":"Microwave ablation versus resection for colorectal cancer liver metastases - a propensity score analysis from a population-based nationwide registry","volume":"46","author":"Tinguely P","year":"2020","unstructured":"Tinguely P, Dal G, Bottai M, Nilsson H, Freedman J, Engstrand J. Microwave ablation versus resection for colorectal cancer liver metastases - a propensity score analysis from a population-based nationwide registry. Eur J Surg Oncol. 2020, 46:476-85. 10.1016\/j.ejso.2019.12.002","journal-title":"Eur J Surg Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2020.08.002","article-title":"Real-world treatment and outcomes of metastatic colorectal cancer patients with a poor or very poor performance status","volume":"20","author":"Travers A","year":"2021","unstructured":"Travers A, Jalali A, Begbie S, et al.. Real-world treatment and outcomes of metastatic colorectal cancer patients with a poor or very poor performance status. Clin Colorectal Cancer. 2021, 20:e21-34. 10.1016\/j.clcc.2020.08.002","journal-title":"Clin Colorectal Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092091","article-title":"Clinical effectiveness of oncological treatment in metastatic colorectal cancer is independent of comorbidities and age","volume":"13","author":"Nieders\u00fc\u00df-Beke D","year":"2021","unstructured":"Nieders\u00fc\u00df-Beke D, Orlinger M, Falch D, et al.. Clinical effectiveness of oncological treatment in metastatic colorectal cancer is independent of comorbidities and age. Cancers (Basel). 2021, 13:10.3390\/cancers13092091","journal-title":"Cancers (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081751","article-title":"Impact of age and comorbidity on multimodal management and survival from colorectal cancer: a population-based study","volume":"10","author":"Kellokumpu I","year":"2021","unstructured":"Kellokumpu I, Kairaluoma M, Mecklin JP, et al.. Impact of age and comorbidity on multimodal management and survival from colorectal cancer: a population-based study. J Clin Med. 2021, 10:10.3390\/jcm10081751","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215208","article-title":"Predictors of survival in elderly patients with metastatic colon cancer: a population-based cohort study","volume":"14","author":"Badic B","year":"2022","unstructured":"Badic B, Bouvier AM, Bouvier V, et al.. Predictors of survival in elderly patients with metastatic colon cancer: a population-based cohort study. Cancers (Basel). 2022, 14:10.3390\/cancers14215208","journal-title":"Cancers (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2022.01.006","article-title":"Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis","volume":"13","author":"McCleary NJ","year":"2022","unstructured":"McCleary NJ, Zhang S, Ma C, et al.. Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis. J Geriatr Oncol. 2022, 13:469-79. 10.1016\/j.jgo.2022.01.006","journal-title":"J Geriatr Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1101771","article-title":"Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer","volume":"11","author":"Gheybi K","year":"2023","unstructured":"Gheybi K, Buckley E, Vitry A, Roder D. Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer. Front Public Health. 2023, 11:1101771. 10.3389\/fpubh.2023.1101771","journal-title":"Front Public Health"},{"key":"ref27","article-title":"Multimorbidity in people living with and beyond cancer: a scoping review","volume":"13","author":"Ahmad TA","year":"2023","unstructured":"Ahmad TA, Gopal DP, Chelala C, Dayem Ullah AZ, Taylor SJ. Multimorbidity in people living with and beyond cancer: a scoping review. Am J Cancer Res. 2023, 13:4346-65.","journal-title":"Am J Cancer Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02838-w","article-title":"Comorbidity in patients with cancer treated at The Christie","volume":"131","author":"Abravan A","year":"2024","unstructured":"Abravan A, Faivre-Finn C, Gomes F, van Herk M, Price G. Comorbidity in patients with cancer treated at The Christie. Br J Cancer. 2024, 131:1279-89. 10.1038\/s41416-024-02838-w","journal-title":"Br J Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2006.04.001","article-title":"Comorbid illnesses and health care utilization among Medicare beneficiaries with lung cancer","volume":"59","author":"Dy SM","year":"2006","unstructured":"Dy SM, Sharkey P, Herbert R, Haddad K, Wu AW. Comorbid illnesses and health care utilization among Medicare beneficiaries with lung cancer. Crit Rev Oncol Hematol. 2006, 59:218-25. 10.1016\/j.critrevonc.2006.04.001","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp23X732129","article-title":"Self-ageism among older rural people","volume":"73","author":"Ohta R","year":"2023","unstructured":"Ohta R. Self-ageism among older rural people. Br J Gen Pract. 2023, 73:110. 10.3399\/bjgp23X732129","journal-title":"Br J Gen Pract"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2022.09.014","article-title":"A scoping review of ageism towards older adults in cancer care","volume":"14","author":"Haase KR","year":"2023","unstructured":"Haase KR, Sattar S, Pilleron S, et al.. A scoping review of ageism towards older adults in cancer care. J Geriatr Oncol. 2023, 14:101385. 10.1016\/j.jgo.2022.09.014","journal-title":"J Geriatr Oncol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S70942","article-title":"Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads","volume":"10","author":"Schroyen S","year":"2015","unstructured":"Schroyen S, Adam S, Jerusalem G, Missotten P. Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads. Clin Interv Aging. 2015, 10:117-25. 10.2147\/CIA.S70942","journal-title":"Clin Interv Aging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422201-impact-of-comorbidity-burden-on-clinical-outcomes-in-older-adults-with-metastatic-colorectal-cancer-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:45:11Z","timestamp":1759916711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422201-impact-of-comorbidity-burden-on-clinical-outcomes-in-older-adults-with-metastatic-colorectal-cancer-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.94099","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}